Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest in USD of Stemtech Corp from Q4 2019 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.
Summary
Stemtech Corp quarterly Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest history and change rate from Q4 2019 to Q3 2025.
  • Stemtech Corp Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest for the quarter ending 30 Sep 2025 was -$6.55M.
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Quarterly (USD)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, YoY Quarterly Change (%)

Stemtech Corp Quarterly Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 -$6.55M 30 Sep 2025 10-Q 19 Nov 2025
Q2 2025 -$6.45M -$1.52M -30.9% 30 Jun 2025 10-Q 19 Aug 2025
Q1 2025 -$5.68M -$1.24M -27.8% 31 Mar 2025 10-Q 17 Jul 2025
Q4 2024 -$5.23M -$2.45M -88.1% 31 Dec 2024 10-Q 19 Nov 2025
Q2 2024 -$4.93M -$1.24M -33.5% 30 Jun 2024 10-Q 27 Aug 2024
Q1 2024 -$4.45M +$267K +5.67% 31 Mar 2024 10-Q 27 Aug 2024
Q4 2023 -$2.78M +$393K +12.4% 31 Dec 2023 10-Q 19 Nov 2025
Q3 2023 -$1.7M +$3.02M +64% 30 Sep 2023 10-Q 01 Dec 2023
Q2 2023 -$3.69M +$25.1M +87.2% 30 Jun 2023 10-Q 27 Aug 2024
Q1 2023 -$4.71M -$101K -2.2% 31 Mar 2023 10-Q 27 Aug 2024
Q4 2022 -$3.17M +$834K +20.8% 31 Dec 2022 10-Q 19 Nov 2025
Q3 2022 -$4.72M -$283K -6.39% 30 Sep 2022 10-Q 01 Dec 2023
Q2 2022 -$28.8M -$28.5M -11505% 30 Jun 2022 10-Q 01 Dec 2023
Q1 2022 -$4.61M -$5.51M -615% 31 Mar 2022 10-Q 22 Aug 2023
Q4 2021 -$4.01M -$5.27M -416% 31 Dec 2021 10-K 10 Jul 2024
Q3 2021 -$4.43M 30 Sep 2021 10-Q 23 Nov 2022
Q2 2021 -$248K 30 Jun 2021 10-Q 23 Nov 2022
Q1 2021 $896K 31 Mar 2021 10-Q 23 Aug 2022
Q4 2020 $1.27M +$1.47M 31 Dec 2020 10-K 17 Apr 2023
Q4 2019 -$198K 31 Dec 2019 10-K 01 Apr 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.